REPL::Placements::Proposed Subscription of 4,600,000 New Ordinary Shares - Receipt of Approval In-Principle
Issuer & Securities
Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No
Announcement Details
Announcement Title
Placements
Date &Time of Broadcast
28-Mar-2023 20:31:38
Status
Replacement
Announcement Sub Title
Proposed Subscription of 4,600,000 New Ordinary Shares - Receipt of Approval In-Principle
Announcement Reference
SG230320OTHRH37S
Submitted By (Co./ Ind. Name)
Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.
Additional Details
Capital Amount-Old
SGD 17,025,532.94
Capital Amount-New
SGD 17,485,532.94
No. of Existing Outstanding Shares
23,000,000
New Shares Issued
4,600,000
Offer Price
SGD 0.1
Attachments
20230328 - Placement - Approval In-Principle from the SGX-ST - Pharmesis.pdf
Total size =62K
Related Announcements
Related Announcements
20/03/2023 18:37:07